Citigroup’s NCI, Inc. NCIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-8,782
| Closed | -$185K | – | 7657 |
|
|
2017
Q2 | $185K | Buy |
8,782
+2,128
| +32% | +$36.5K | ﹤0.01% | 4871 |
|
|
2017
Q1 | $100K | Sell |
6,654
-6,136
| -48% | -$86.2K | ﹤0.01% | 5218 |
|
|
2016
Q4 | $178K | Buy |
12,790
+3,369
| +36% | +$42.5K | ﹤0.01% | 5374 |
|
|
2016
Q3 | $109K | Buy |
9,421
+8,820
| +1,468% | +$110K | ﹤0.01% | 5148 |
|
|
2016
Q2 | $8K | Buy |
+601
| New | +$8.28K | ﹤0.01% | 6669 |
|
|
2015
Q4 | – | Sell |
-7
| Closed | – | – | 8101 |
|
|
2015
Q3 | $0 | Buy |
+7
| New | +$88 | ﹤0.01% | 8047 |
|
|
2015
Q2 | – | Sell |
-3,564
| Closed | -$36K | – | 7948 |
|
|
2015
Q1 | $36K | Sell |
3,564
-1,743
| -33% | -$19.7K | ﹤0.01% | 5743 |
|
|
2014
Q4 | $54K | Sell |
5,307
-420
| -7% | -$4.42K | ﹤0.01% | 5648 |
|
|
2014
Q3 | $54K | Buy |
5,727
+1,829
| +47% | +$17.1K | ﹤0.01% | 5268 |
|
|
2014
Q2 | $35K | Buy |
3,898
+44
| +1% | +$426 | ﹤0.01% | 5430 |
|
|
2014
Q1 | $41K | Buy |
+3,854
| New | +$35.7K | ﹤0.01% | 5626 |
|
|
2013
Q4 | – | Sell |
-5
| Closed | – | – | 7264 |
|
|
2013
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 7127 |
|
|
2013
Q2 | $0 | Buy |
+5
| New | +$23 | ﹤0.01% | 6844 |
|
Citigroup's NCIT Position: Q3 2017 in Review
Citigroup sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 8,782 shares — an estimated $185K sold.
Citigroup first reported a position in NCIT in Q2 2013 and held it in 13 quarters. The position peaked at $185K in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.
- Citigroup reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
- Citigroup sold 8,782 NCI, Inc. shares in Q3 2017, an estimated $185K.
- Citigroup first reported a position in NCI, Inc. in Q2 2013 and held it in 13 quarters.
- Citigroup's NCI, Inc. position peaked at $185K in Q2 2017.
- 0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.
Based on Citigroup's 13F filing for Q3 2017, filed 13 Nov 2017.